CN101843772A - Chinese medicament for treating diabetic oculopathy - Google Patents
Chinese medicament for treating diabetic oculopathy Download PDFInfo
- Publication number
- CN101843772A CN101843772A CN200910235884A CN200910235884A CN101843772A CN 101843772 A CN101843772 A CN 101843772A CN 200910235884 A CN200910235884 A CN 200910235884A CN 200910235884 A CN200910235884 A CN 200910235884A CN 101843772 A CN101843772 A CN 101843772A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- chinese
- chinese medicine
- chinese medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicament for treating diabetic oculopathy, and belongs to the field of Chinese medicaments for treating ophthalmology and otorhinolaryngology diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: dipsacus root, medlar, fresh rehmannia root, barbed skullcap herb, lucid ganoderma, Chinese angelica, chrysanthemum, radix pseudo-ginseng and the like. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, activating blood and dissolving stasis, nourishing liver and kidney, and clearing liver and improving vision, and has the advantages of obvious effect, exact medicinal effect and quick response.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment diseases of the five sense organs.
Background technology
Diabetic ophthalmopathy is one of diabetes common complication, mainly is diabetic retinopathy.The present Chinese medicine that is intended to treat diabetic ophthalmopathy, it is significantly not enough to exist some: the one, and effect is obvious inadequately, the 2nd, it is slower to take effect, to such an extent as to large quantities of diabetic eye patients are owing to can not get the effective treatment and the control of medicine, oculopathy progressively increases the weight of, eyes are dry and astringent, blurred vision, vision are seriously low, develop into blind at last.Patient and family members thereof are very dissatisfied to this.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of diabetic ophthalmopathy, it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of diabetic ophthalmopathy adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Radix Dipsaci 4-25 part Fructus Lycii 5-30 part Radix Rehmanniae 5-30 part
Herba Scutellariae Barbatae 4-25 part Ganoderma 2-15 part Radix Angelicae Sinensis 5-30 part
Flos Chrysanthemi 3-20 part Radix Notoginseng 3-20 part
The Chinese medicine of this treatment diabetic ophthalmopathy is made by following method:
(1) by above-mentioned weight ratio, Radix Dipsaci, Fructus Lycii, Radix Rehmanniae, Herba Scutellariae Barbatae, Radix Angelicae Sinensis, Flos Chrysanthemi are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma, Radix Rehmanniae the body resistance strengthening and constitution consolidating, benefiting QI and nourishing blood in the side; Radix Angelicae Sinensis, pseudo-ginseng blood-circulation-invigovating blood stasis dispelling are promoted blood circulation; Last four flavor phases 5, enhancing human body immunity power promotes crystal and retinal microcirculation, the microangiopathies of relieving retina; Be aided with the Radix Dipsaci nourishing liver and kidney; The Herba Scutellariae Barbatae heat-clearing and toxic substances removing; Fructus Lycii, Flos Chrysanthemi benefit Jingming order.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, nourishing the liver and kidney, the merit of clearing away heat to improve acuity of vision, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Radix Dipsaci 60 gram Fructus Lycii 70 gram Radix Rehmanniae 7 grams
Herba Scutellariae Barbatae 60 kairine sesames 30 gram Radix Angelicae Sinensis 70 grams
Flos Chrysanthemi 50 gram Radix Notoginseng 40 grams
Weight in accordance with regulations, with conventional water extraction process Radix Dipsaci, Fructus Lycii, Radix Rehmanniae, Herba Scutellariae Barbatae, Radix Angelicae Sinensis, Flos Chrysanthemi are extracted, make extractum fine powder 114 grams, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 657 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Radix Dipsaci 180 gram Fructus Lycii 180 gram Radix Rehmanniae 180 grams
Herba Scutellariae Barbatae 180 kairine sesames 90 gram Radix Angelicae Sinensis 180 grams
Flos Chrysanthemi 120 gram Radix Notoginseng 120 grams
By above-mentioned same method, make 1843 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Radix Dipsaci 250 gram Fructus Lycii 300 gram Radix Rehmanniae 300 grams
Herba Scutellariae Barbatae 250 kairine sesames 150 gram Radix Angelicae Sinensis 300 grams
Flos Chrysanthemi 200 gram Radix Notoginseng 200 grams
By above-mentioned same method, make 2964 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
6 parts of 6 parts of Radix Rehmanniae of 5.5 parts of Fructus Lycii of Radix Dipsaci
6 parts of 3 parts of Radix Angelicae Sinensis of 5.5 portions of Ganodermas of Herba Scutellariae Barbatae
4 parts of 4 portions of Radix Notoginseng of Flos Chrysanthemi
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
25 parts of 25 parts of Radix Rehmanniae of 20 parts of Fructus Lycii of Radix Dipsaci
25 parts of 12 parts of Radix Angelicae Sinensis of 20 portions of Ganodermas of Herba Scutellariae Barbatae
16 parts of 15 portions of Radix Notoginseng of Flos Chrysanthemi
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science diabetic ophthalmopathy (retinopathy), through 12 routine clinical observations.Selecting the tcm diagnosis diabetic retinopathy is standard: diabetics is had a dizzy spell, and gum is too much; Binocular dryness, eye socket pain; Visual deterioration, blurred vision; That retina occurs is hemorrhage, edema, ooze out.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 7 examples, women's 5 examples do not have other serious disease, and the age is 46 years old-77 years old, 61.7 years old mean age.
Efficacy determination:
1, produce effects: gum is normal, eyes Clear and Bright; Binocular dryness disappears, and eyes are comfortable; Blurred vision is alleviated, and vision improves more than 0.1; White macula, macula lutea, the minimizing of blood stain quantity appear in the optical fundus, and area dwindles.
2, effective: the dry and astringent disappearance of eyes, blurred vision is alleviated.
3, invalid: the disease no change.
During clinical experiment, except that the antidiabetic drug that diabetics is necessary is taken (medicine is constant, amount is constant) as usual, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 2 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 3 months after, symptom is obviously improved.12 philtrums of clinical experiment, produce effects 5 people, effective 6 people, invalid 1 people, total effective rate 91.6%.
Claims (1)
1. a Chinese medicine for the treatment of diabetic ophthalmopathy adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Radix Dipsaci 4---30 parts of 25 parts of Fructus Lycii 5---30 parts of Radix Rehmanniae 5---
Herba Scutellariae Barbatae 4---30 parts of 25 portions of Ganodermas 2---15 parts of Radix Angelicae Sinensis 5---
20 parts of Flos Chrysanthemis 3---20 portions of Radix Notoginseng 3---
The Chinese medicine of this treatment diabetic ophthalmopathy is made by following method:
(1) by above-mentioned weight ratio, Radix Dipsaci, Fructus Lycii, Radix Rehmanniae, Herba Scutellariae Barbatae, Radix Angelicae Sinensis, Flos Chrysanthemi are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910235884A CN101843772A (en) | 2009-10-28 | 2009-10-28 | Chinese medicament for treating diabetic oculopathy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910235884A CN101843772A (en) | 2009-10-28 | 2009-10-28 | Chinese medicament for treating diabetic oculopathy |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101843772A true CN101843772A (en) | 2010-09-29 |
Family
ID=42768710
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910235884A Pending CN101843772A (en) | 2009-10-28 | 2009-10-28 | Chinese medicament for treating diabetic oculopathy |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101843772A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102389484A (en) * | 2011-07-23 | 2012-03-28 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating diabetic retinopathy |
-
2009
- 2009-10-28 CN CN200910235884A patent/CN101843772A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102389484A (en) * | 2011-07-23 | 2012-03-28 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating diabetic retinopathy |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101530502B (en) | Traditional Chinese medicine for treating diabetic fundus hemorrhage | |
CN101843837B (en) | Chinese medicament for treating diabetic oculopathy | |
CN101884693B (en) | Traditional Chinese medicine for treating diabetic eye diseases | |
CN101843786A (en) | Chinese medicament for treating diabetic eyeground pathological changes | |
CN101843836B (en) | Chinese medicament for treating diabetic oculopathy | |
CN101843772A (en) | Chinese medicament for treating diabetic oculopathy | |
CN101391071B (en) | Traditional Chinese medicine for treating diabetic ocular fundus diseases | |
CN102389484A (en) | Traditional Chinese medicine for treating diabetic retinopathy | |
CN101843834B (en) | Chinese medicament for treating diabetic eyeground pathological changes | |
CN101843857B (en) | Chinese medicament for treating diabetic eyeground pathological changes | |
CN101843770A (en) | Chinese medicament for treating diabetic oculopathy | |
CN101843727A (en) | Chinese medicament for treating diabetic oculopathy | |
CN101843788A (en) | Chinese medicament for treating diabetic oculopathy | |
CN101897809A (en) | Traditional Chinese medicine for treating diabetic retinopathy | |
CN102018757A (en) | Traditional Chinese medicine for treating eyeground pathological changes caused by diabetes | |
CN101940659A (en) | Traditional Chinese medicine for treating diabetic eye disease | |
CN101953939A (en) | Chinese medicament for treating diabetic eye diseases | |
CN101972343A (en) | Traditional Chinese medicine for treating diabetic oculopathy | |
CN101843774A (en) | Chinese medicament for treating diabetic eyeground pathological changes | |
CN101843728A (en) | Chinese medicament for treating diabetic oculopathy | |
CN101843725A (en) | Chinese medicament for treating diabetic oculopathy | |
CN101843705A (en) | Chinese medicament for treating lupus erythematosus | |
CN101843785A (en) | Chinese medicament for treating diabetic eyeground pathological changes | |
CN101843752A (en) | Chinese medicament for treating diabetic eyeground pathological changes | |
CN102018785A (en) | Traditional Chinese medicine for treating diabetes fundus lesions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20100929 |